Camp4 (CAMP) Director Richard Young Buys 16,378 Shares

What Happened
Richard A. Young, a director of Camp4 Therapeutics Corp (CAMP), acquired 16,378 shares on August 3, 2026 in the second closing of a private placement. The shares were purchased at $1.65 per share for a total cash outlay of approximately $27,024. This was a purchase (transaction code P), not a sale.

Key Details

• Transaction date: August 3, 2026 (Period of Report: 2026-08-03)
• Filing date: August 5, 2026 (Accession: 0001628280-26-053513) — no indication in the filing that it was late
• Price per share: $1.65; Shares acquired: 16,378; Total value: ~$27,024
• Shares owned after transaction: not disclosed in this Form 4 filing
• Footnote: Acquisition occurred in the second closing of a private placement under a Securities Purchase Agreement dated Sept 9, 2025, as amended Aug 3, 2026, involving institutional investors and certain directors, employees, and consultants (purchase price $1.65/share)

Context
This was a private placement (not an open-market buy), meaning the shares were purchased under negotiated terms in a financing that involved other investors and insiders. Purchases by directors can be watched as a signal of insider participation, but this single transaction is modest in dollar size (~$27k) and should be considered alongside other filings and company fundamentals.